SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-002235
Filing Date
2021-01-14
Accepted
2021-01-14 16:11:26
Documents
44
Period of Report
2020-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1120_oramedpharma.htm 10-Q 323152
2 CERTIFICATION f10q1120ex31-1_oramedpharma.htm EX-31.1 9225
3 CERTIFICATION f10q1120ex31-2_oramedpharma.htm EX-31.2 8993
4 CERTIFICATION f10q1120ex32-1_oramedpharma.htm EX-32.1 3090
5 CERTIFICATION f10q1120ex32-2_oramedpharma.htm EX-32.2 3119
6 GRAPHIC image_001.jpg GRAPHIC 36055
  Complete submission text file 0001213900-21-002235.txt   2266066

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ormp-20201130.xml EX-101.INS 291331
8 XBRL SCHEMA FILE ormp-20201130.xsd EX-101.SCH 31473
9 XBRL CALCULATION FILE ormp-20201130_cal.xml EX-101.CAL 26920
10 XBRL DEFINITION FILE ormp-20201130_def.xml EX-101.DEF 137139
11 XBRL LABEL FILE ormp-20201130_lab.xml EX-101.LAB 287965
12 XBRL PRESENTATION FILE ormp-20201130_pre.xml EX-101.PRE 141795
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 21528838
SIC: 2834 Pharmaceutical Preparations